Biosynex Logo

Biosynex

ALBIO | PA

Overview

Corporate Details

ISIN(s):
FR0011005933
LEI:
969500H4BGE1HBLGP566
Country:
France
Address:
22 BOULEVARD SEBASTIEN BRANT, 67400 ILLKIRCH-GRAFFENSTADEN
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Founded in 2005, Biosynex is a key European manufacturer specializing in the in-vitro diagnostics market. The company designs, manufactures, and distributes Rapid Diagnostic Tests (RDTs) for both professional and public use. Its product portfolio includes Point-of-Care (POC) solutions, molecular biology assays, and self-tests available in pharmacies, which are utilized for screening, diagnosis, and prevention. Biosynex's tests are engineered for speed and simplicity, aiming to facilitate better medical management and patient care. The company distributes its products internationally to over 90 countries, serving healthcare professionals such as biologists and doctors, as well as the general consumer market.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Biosynex. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-29 18:45
Regulatory News Service
BIOSYNEX SA: LA FOOD AND DRUG ADMINSITRATION ATTRIBUE LE STATUT BREAKTHROUGH DE…
French 28.7 KB
2025-07-17 18:00
Earnings Release
BIOSYNEX SA: CHIFFRE DAFFAIRES DU PREMIER SEMESTRE 2025 : 50,8 M (-6%)
French 50.6 KB
2025-06-17 18:00
Regulatory News Service
BIOSYNEX SA: LA FOOD AND DRUG ADMINSITRATION ATTRIBUE LE STATUT “BREAKTHROUGH D…
French 329.2 KB
2025-06-17 18:00
Regulatory News Service
BIOSYNEX SA: LA FOOD AND DRUG ADMINSITRATION ATTRIBUE LE STATUT BREAKTHROUGH DE…
French 29.2 KB
2025-04-23 18:00
Earnings Release
BIOSYNEX SA: RESULTATS ANNUELS 2024 - ACCELERATION DE LA REORGANISATION DU GROU…
French 389.4 KB
2025-04-23 18:00
Earnings Release
BIOSYNEX SA: RESULTATS ANNUELS 2024 - ACCELERATION DE LA REORGANISATION DU GROU…
French 108.9 KB
2025-03-06 18:03
Major Shareholding Notification
Franchissement de seuil
French 221.4 KB
2025-03-05 18:00
Declaration of Voting Results & Voting Rights Announcements
BIOSYNEX SA: DECLARATION DU NOMBRE DACTIONS ET DES DROITS DE VOTE AU 28 FEVRIER…
French 23.2 KB
2025-03-04 18:00
Declaration of Voting Results & Voting Rights Announcements
BIOSYNEX SA: DECLARATION DU NOMBRE D’ACTIONS ET DES DROITS DE VOTE AU 28 FEVRIE…
French 127.2 KB
2025-03-04 18:00
Declaration of Voting Results & Voting Rights Announcements
BIOSYNEX SA: DECLARATION DU NOMBRE DACTIONS ET DES DROITS DE VOTE AU 28 FEVRIER…
French 23.2 KB
2025-03-04 17:00
Declaration of Voting Results & Voting Rights Announcements
BIOSYNEX SA: DECLARATION DU NOMBRE D’ACTIONS ET DES DROITS DE VOTE AU 28 FEVRIE…
French 127.2 KB
2025-02-13 08:00
Share Issue/Capital Change
BIOSYNEX SA: BIOSYNEX ANNONCE LE SUCCES DE SON AUGMENTATION DE CAPITAL AVEC MAI…
French 120.7 KB
2025-02-12 08:00
Share Issue/Capital Change
BIOSYNEX SA: BIOSYNEX ANNONCE LE SUCCES DE SON AUGMENTATION DE CAPITAL AVEC MAI…
French 120.7 KB
2025-02-12 08:00
Share Issue/Capital Change
BIOSYNEX SA: BIOSYNEX ANNONCE LE SUCCES DE SON AUGMENTATION DE CAPITAL AVEC MAI…
French 120.7 KB
2025-01-22 07:00
Share Issue/Capital Change
BIOSYNEX SA: LANCEMENT D’UNE AUGMENTATION DE CAPITAL AVEC MAINTIEN DU DROIT PRE…
French 543.0 KB

Automate Your Workflow. Get a real-time feed of all Biosynex filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Biosynex via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK